🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate safety and determine the recommended Phase II dose (RP2D). We h...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2025-03-05
Trial ID
NCT06548230
Treatments Being Tested
Triple negative breast cancer (TNBC) represents approximately 15% of all br...
Status
Completed
Location
Hospital Universitario Virgen de las Nieves
Start Date
2022-01-11
Trial ID
NCT05181462
Treatments Being Tested
This study will consider the safety and effectiveness of a study drug, CAN0...
Status
Completed
Location
EDOG - Institut Bergonie - PPDS
Start Date
2021-07-19
Trial ID
NCT04990037
Treatments Being Tested
Phase 1b/2 open-label study evaluates the safety, tolerability, and efficac...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2025-12-01
Trial ID
NCT07281716
Treatments Being Tested
The main purpose of this study is to assess nadunolimab as an immunoprevent...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2026-05-21
Trial ID
NCT07284485
Treatments Being Tested
This is a Phase 1/2, open-label, multicentric, non-randomised, parallel-arm...
Status
Completed
Location
EDOG Institut de Cancerologie de l'Ouest - PPDS
Start Date
2021-09-22
Trial ID
NCT05116891
Treatments Being Tested